Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Sensors (Basel) ; 22(5)2022 Feb 25.
Artículo en Inglés | MEDLINE | ID: mdl-35270973

RESUMEN

The application of agricultural robots can liberate labor. The improvement of robot sensing systems is the premise of making it work. At present, more research is being conducted on weeding and harvesting systems of field robot, but less research is being conducted on crop disease and insect pest perception, nutritional element diagnosis and precision fertilizer spraying systems. In this study, the effects of the nitrogen application rate on the absorption and accumulation of nitrogen, phosphorus and potassium in sweet maize were determined. Firstly, linear, parabolic, exponential and logarithmic diagnostic models of nitrogen, phosphorus and potassium contents were constructed by spectral characteristic variables. Secondly, the partial least squares regression and neural network nonlinear diagnosis model of nitrogen, phosphorus and potassium contents were constructed by the high-frequency wavelet sensitivity coefficient of binary wavelet decomposition. The results show that the neural network nonlinear diagnosis model of nitrogen, phosphorus and potassium content based on the high-frequency wavelet sensitivity coefficient of binary wavelet decomposition is better. The R2, MRE and NRMSE of nn of nitrogen, phosphorus and potassium were 0.974, 1.65% and 0.0198; 0.969, 9.02% and 0.1041; and 0.821, 2.16% and 0.0301, respectively. The model can provide growth monitoring for sweet corn and a perception model for the nutrient element perception system of an agricultural robot, while making preliminary preparations for the realization of intelligent and accurate field fertilization.


Asunto(s)
Robótica , Agricultura/métodos , Algoritmos , Fertilizantes , Fósforo
2.
Brain Imaging Behav ; 13(2): 503-513, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29736883

RESUMEN

Several resting-state neuroimaging studies have indicated abnormal regional homogeneity (ReHo) in chronic schizophrenia; however, little work has been conducted to investigate naïve patients with first-episode schizophrenia (FES). Even less investigated is the association between ReHo measures and clinical symptom severity in naïve patients with FES. The current study evaluated ReHo alterations in whole brain, and assessed the correlations between ReHo measures and clinical variables in naïve patients with FES. Forty-four naïve patients with FES and 26 healthy controls (HC) underwent resting-state functional magnetic resonance imaging (rs-fMRI). Group-level analysis was utilized to analyze the ReHo differences between FES and HC in a voxel-by-voxel manner. Severity of symptoms was evaluated using a five-factor model of the Positive and Negative Syndrome Scale (PANSS). The correlation between the severity of symptoms and ReHo map was examined in patients using voxel-wise correlation analyses within brain areas that showed a significant ReHo alteration in patients compared with controls. Compared with the healthy control group, the FES group showed a significant decrease in ReHo values in the left medial frontal gyrus (MFG), right precentral gyrus, left superior temporal gyrus (STG), left left middle temporal gyrus (MTG), left thalamus, and significant increase in ReHo values in the left MFG, left inferior parietal lobule (IPL), left precuneus, and right lentiform nucleus (LN). In addition, the correlation analysis showed the PANSS total score negatively correlated with ReHo in the right precentral gyrus and positively correlated with ReHo in the left thalamus, the positive factor positively correlated with ReHo in the right thalamus, the disorganized/concrete factor positively correlated with ReHo in left posterior cingulate gyrus (PCG), the excited factor positively correlated with ReHo in the left precuneus, and the depressed factor negatively correlated with ReHo in the right postcentral gyrus and positively correlated with ReHo in the right thalamus. Our results indicate that widespread ReHo abnormalities occurred in an early stage of schizophrenic onset, suggesting a potential neural basis for the pathogenesis and symptomatology of schizophrenia.


Asunto(s)
Mapeo Encefálico , Encéfalo/diagnóstico por imagen , Encéfalo/fisiopatología , Esquizofrenia/diagnóstico por imagen , Esquizofrenia/fisiopatología , Adulto , Escalas de Valoración Psiquiátrica Breve , Femenino , Lóbulo Frontal/fisiopatología , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Lóbulo Parietal/fisiopatología , Lóbulo Temporal/fisiopatología , Tálamo/fisiopatología , Adulto Joven
3.
PLoS One ; 12(1): e0169882, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28118359

RESUMEN

Voltage-gated sodium channels (VGSC) regulate neuronal excitability by governing action potential (AP) generation and propagation. Recent studies have revealed that AMP-activated protein kinase (AMPK) activators decrease sensory neuron excitability, potentially by preventing sodium (Na+) channel phosphorylation by kinases such as ERK or via modulation of translation regulation pathways. The direct positive allosteric modulator A769662 displays substantially greater efficacy than other AMPK activators in decreasing sensory neuron excitability suggesting additional mechanisms of action. Here, we show that A769662 acutely inhibits AP firing stimulated by ramp current injection in rat trigeminal ganglion (TG) neurons. PT1, a structurally dissimilar AMPK activator that reduces nerve growth factor (NGF) -induced hyperexcitability, has no influence on AP firing in TG neurons upon acute application. In voltage-clamp recordings, application of A769662 reduces VGSC current amplitudes. These findings, based on acute A769662 application, suggest a direct channel blocking effect. Indeed, A769662 dose-dependently blocks VGSC in rat TG neurons and in Nav1.7-transfected cells with an IC50 of ~ 10 µM. A769662 neither displayed use-dependent inhibition nor interacted with the local anesthetic (LA) binding site. Popliteal fossa administration of A769662 decreased noxious thermal responses with a peak effect at 5 mins demonstrating an analgesic effect. These data indicate that in addition to AMPK activation, A769662 acts as a direct blocker/modulator of VGSCs, a potential mechanism enhancing the analgesic property of this compound.


Asunto(s)
Proteínas Quinasas Activadas por AMP/efectos de los fármacos , Analgésicos/farmacología , Canal de Sodio Activado por Voltaje NAV1.7/efectos de los fármacos , Pironas/farmacología , Células Receptoras Sensoriales/efectos de los fármacos , Bloqueadores de los Canales de Sodio/farmacología , Tiofenos/farmacología , Anestésicos Locales/metabolismo , Animales , Sitios de Unión/genética , Compuestos de Bifenilo , Evaluación Preclínica de Medicamentos , Células HEK293 , Calor/efectos adversos , Humanos , Masculino , Metformina/farmacología , Canal de Sodio Activado por Voltaje NAV1.7/genética , Conducción Nerviosa/efectos de los fármacos , Dolor/tratamiento farmacológico , Técnicas de Placa-Clamp , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/efectos de los fármacos , Proteínas Recombinantes de Fusión/efectos de los fármacos , Proteínas Recombinantes de Fusión/metabolismo , Resveratrol , Células Receptoras Sensoriales/enzimología , Estilbenos/farmacología , Tiazoles/farmacología , Ganglio del Trigémino/efectos de los fármacos , metaminobenzoatos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA